Keywords: 4th-qtr, sales, drop, low, rx, health, care
J&J's 4th-qtr 2005 sales drop 1.1% on low Rx
Article | 30 January 2006
US health care giant Johnson & Johnson says that sales in fourth-quarter 2005 totaled $12.6 billion, a 1.1% decline on the comparable period of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
